Broaden your audience, analyst tells biotechs
Tuesday, 16 September, 2003
Biotechnology companies need to widen the audiences they pitch their messages to, industry analyst David Blake, of BioShares, told attendees at a BioMelbourne Network breakfast meeting today.
"You have to go beyond the audiences you think you want to talk to," said Blake.
He noted that while it was important to communicate with stakeholders including shareholders, regulatory bodies, and potential investors, companies needed to also develop messages for consumers, non-investors, and society's decision makers, including policy makers. And companies should not ignore other economic sectors either.
It was also important to develop positive relationships with the media, and not just with the business-focused media, Blake said. Negative images had the potential to affect the whole industry, not just one company, he said.
"If you can't describe the benefits to all of these audiences, then you should get out of the game," Blake said.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
